| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4cdf984e52e386742b6ba53f2672f7d3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55511
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-51 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-80 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-106 |
| filingDate |
1995-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49031fecaae95f242e3fa800955b09d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a18606a6d7ef44be49b305c73c8004d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_924c489d48591d4bf7e987c55977b97c |
| publicationDate |
1996-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2732605-A1 |
| titleOfInvention |
COMPOSITION FOR INDUCING MUCOSAL IMMUNE RESPONSE |
| abstract |
The subject of the invention is a pharmaceutical composition intended to induce in a host mammal, a protective immune response against an antigen, at the level of an effector mucosal site, which comprises at least two identical or different products each containing an agent inducing the immune response selected from the antigen and provided that the antigen is of a protein nature, an expression cassette capable of expressing the antigen, for concomitant or consecutive administration; one of the products being formulated so as to be administered via the nasal-oral route so that the inducing agent is targeted towards the site (s) inducing an immune response at the level of the nasopharynx or salivary glands, the other product being formulated to be administered via an appropriate mucosal route other than the nasal route so that the inducing agent is targeted towards the site (s) inducing an immune response to level of the effector site where the immune response is sought. Optionally, such a composition can also comprise a third product, identical or different to the first two, formulated to be administered systemically. |
| priorityDate |
1995-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |